XRAY catalysts
Catalysts and events linked to XRAY, newest first.
XRAY stock catalysts and risks
Latest published review: 2026-10-20
| Development | Transmission channel | Evidence | Condition to watch |
|---|---|---|---|
| Dentsply Sirona Beats Q2 EPS at $0.52 and Reaffirms FY26 Sales Outlook 2026-09-09 · Up | earnings beat driven by healthcare segment margin preservation against soft dental sales | XRAY exceeded Q2 adjusted EPS estimates with 52 cents vs 36 cents consensus and reiterated FY26 guidance. | Not recorded |
| Dentsply Sirona Beats Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY26 Outlook 2026-09-09 · Up | earnings beat and margin resilience against revenue contraction | Q2 adjusted EPS of $0.52 beat $0.36 consensus; FY26 guidance reaffirmed at $1.40-$1.50 EPS. | Not recorded |
| Dentsply Sirona Beats Q2 EPS Estimates at $0.52 and Reaffirms FY2026 Targets 2026-09-09 · Mixed | healthcare consumable sales resilience offsetting equipment revenue declines | Q2 EPS reached $0.52 vs $0.36 consensus; full-year EPS guidance reaffirmed at $1.40-$1.50. | Not recorded |
| Dentsply Sirona reports Q2 adjusted EPS of $0.52 and maintains $3.5B-$3.6B sales outlook 2026-09-09 · Mixed | operating cost containment cushioning top-line contraction | Q2 adjusted EPS beat at $0.52 vs $0.36 consensus despite 4.1% YoY revenue decline. | Not recorded |
| Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms FY2026 Sales Guidance 2026-09-09 · Mixed | cost-control pass-through to operating earnings against top-line contraction | Reported Q2 adjusted EPS of $0.52 vs $0.36 consensus with revenues down 4.1% YoY. | Not recorded |
| Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 Guidance 2026-09-09 · Up | operating margin resilience offsetting top-line revenue decline | Q2 adjusted EPS of $0.52 beat consensus of $0.36 with affirmed full-year EPS guidance of $1.40-$1.50. | Not recorded |
| Dentsply Sirona Q2 EPS Beats at $0.52 Despite 4.1% Revenue Contraction 2026-09-09 · Mixed | operating margin resilience offsetting top-line contraction | Q2 adjusted EPS of $0.52 beat $0.36 consensus while revenue fell 4.1% YoY. | Not recorded |
| Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms Full-Year 2026 Guidance 2026-09-09 · Mixed | earnings beat offset by top-line revenue contraction | Adjusted EPS reached $0.52 vs $0.36 consensus while revenue fell 4.1% YoY. | Not recorded |
Do these developments change your position?
Review XRAY alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
DateCardAvg 5d
- 2026-09-09Dentsply Sirona Beats Q2 Adjusted EPS Consensus at $0.52 and Reaffirms FY26 OutlookXRAY-5.41%
- 2026-09-09Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 GuidanceXRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Reaffirms FY26 Sales OutlookXRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Reaffirms FY26 Sales OutlookXRAY-5.41%
- 2026-09-09Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 GuidanceXRAY-5.41%
- 2026-09-09Dentsply Sirona Q2 adjusted EPS of $0.52 beats $0.36 consensus; guidance maintainedXRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms Full-Year 2026 GuidanceALGN XRAY-5.41%
- 2026-09-09Dentsply Sirona Tops Q2 EPS at $0.52 and Affirms Full-Year $3.5B-$3.6B Sales GuidanceXRAY-5.41%
- 2026-09-09Dentsply Sirona Q2 adjusted EPS of $0.52 beats $0.36 consensus; guidance maintainedALGN XRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Maintains FY26 Revenue OutlookXRAY-5.41%
- 2026-09-09DENTSPLY SIRONA Beats Q2 Adjusted EPS at $0.52 and Reaffirms GuidanceXRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY26 OutlookALGN XRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 EPS Estimates at $0.52 and Reaffirms FY2026 TargetsXRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Affirms FY2026 Sales GuidanceALGN XRAY-5.41%
- 2026-09-09Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 GuidanceALGN XRAY-5.41%
- 2026-09-09Dentsply Sirona Q2 EPS Beats at $0.52 Despite 4.1% Revenue ContractionXRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 Adjusted EPS Consensus at $0.52 and Reaffirms FY26 OutlookXRAY-5.41%
- 2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Reaffirms FY26 Sales OutlookXRAY-5.41%
- 2026-09-09Dentsply Sirona reports Q2 adjusted EPS of $0.52 and maintains $3.5B-$3.6B sales outlookALGN XRAY-5.41%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.